After Approval, Tecartus Continues to Impress in B-Cell ALL
Avastin Regimen Improves Survival in Ovarian Cancer, Including Some HRD-Positive Tumors
Obe-cel Leads to Deep, Durable Responses in B-Cell ALL
Simple Hysterectomy ‘the New Standard’ for Low-Risk, Early Cervical Cancer
